期刊文献+

培他乐克、波依定和洛汀新对高血压病左室重构的影响 被引量:1

Metoprolol、Felodipine, Lotensin on Left Ventricular Remodeling in Hypertensive Patients
下载PDF
导出
摘要 目的 探讨用 β -阻滞剂、钙拮抗剂 (CaA)和血管紧张素转换酶抑制剂 (ACEI)长期治疗对高血压病左室重构的影响。方法  412例高血压病Ⅰ级或Ⅱ级患者服用降压药 5 .3± 0 .7年 ,随机分为 β -阻滞剂组、CaA组、ACEI组、对照组 ,观察疗效及对左室重构的影响。结果 长期服用 β-阻滞剂、CaA或ACEI不仅能使血压稳定在较低水平 ,而且可逆转左室肥厚 ,改善心功能 ,其中尤以 β -阻滞剂为明显 ,它可降低病死率及心源性猝死发生率。而对照组上述指标均较CaA、ACEI和 β-阻滞剂组有加重趋势 ,其加重程度和观察时间呈正相关 (P <0 .0 1)。 结论 长期 β -阻滞剂、CaA或ACEI治疗可逆转左室重构 。 Objective To evaluate long-term effects of β-blocker,calcium antagonist,ACEI on left ventricular remodeling in hypertensive patients.Method 412 patients with hypertension were treated by us and follow up 5.3±0.7 years,they were randomly divided into 4 groups.Result β-blocker,calcium antagonist and ACEI not only have an affirmative effect on high blood pressure,and also have an effect of regressing left ventricular remodeling and improving cardiac function.Most significantly of them is β-blocker,it could decrease mortality and rate of cardiac sudden death.Conclusion β-blocker ,CaA or ACEI might regress left ventricular remodeling and improve prognosis of hypertensive patients.
机构地区 江阴市中医院
出处 《苏州医学院学报》 2000年第10期918-920,共3页 Acta Academiae Medicinae Suzhou
  • 相关文献

参考文献10

  • 11,Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med, 1986, 105∶173~178
  • 22,Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med, 1990,322∶1561~1566
  • 33,Devereux RB, Roman MJ, de Simone G. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation, 1997, 96∶1416~1423
  • 44,Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA, 1996,275∶1507~1513
  • 55,Erley CM, Haefele U, Heyne N,et al. Microalbuminuria in essential hypertension. Reduction by different anti-hypertensive drugs. Hypertension, 1993,21∶ 810~815
  • 66,Anversa P, Olivetti G, Capasso JM. Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol, 1991, 68∶70~79
  • 77,Machnig T, Henneke KH, Engels G, et al.Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy. Cardiology, 1994, 85∶101~110
  • 88,Kendall MJ, Cohen JD. Beta-blockers as first-line agents for hypertension in the elderly. JAMA, 1999, 281∶131~133
  • 99,Kendall MJ, Lynch KP, Hjalmarson A, et al.Beta-blo-ckers and sudden cardiac death. Ann Intern Med, 1995,123∶358~367
  • 1010,Olsson G, Tuomilehto J, Berglund G, et al.Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study. Am J Hypertens, 1991, 4∶151~158

同被引文献27

  • 1王玮,李源,崔致贤,黄晨,张珊红,张勇翔.维拉帕米抑制肥厚心肌细胞提取物促心肌细胞生长作用的研究[J].第四军医大学学报,1996,17(3):194-194. 被引量:5
  • 2Vaux DL., Strasser A. The molecular biology of opoptosis.Proc Natl Acad Sci USA, 1996,93:2239
  • 3Bennett MR., Evan GI., Newby AC., et al. Deregulated expression of the-myconcogeneobolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, intefferon-γ, heporin, and cyclic nudeotide analogues and induces apoptosis. Circulation Research,1994,74 (3) :525
  • 4Dariusz L., Yejun Z., Mikko L., et al. Apoptosis of vascular smooth muscle cells. A Pathol, 1994,145 (6):1265
  • 5Dia S. ,Pollack MD. Proto-oncogenes and the cardiovascular system. CHEST, 1995,107 (3) :826
  • 6Oscar H., Bing L. Hypothesis:opoptosis may be a mechani-sm for the transition to heart failture with chronic pressure overload. J Mol cell Cardiol,1994,26:943
  • 7Nagase-Ml. Do angiotention converting enzyme and calcium channel blocker intervene in the progression of renal disease besides by lowering systemic hypertention?Nippon-Rinsho, 1997,55 (8) :2116-2122
  • 8Matsubara,-L-S. Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction inrenovascular hypertensive rats. Can-J-Physiol-Pharmacol, 1997,75(12):1328-1334
  • 9Linz,-W. Long-term ACE inhibition doubles lffespan of hypertensive rats. Circulation, 1997,96 (9):3164-3172
  • 10Rhaleb-N-E. Effect of ACE inhibitor on DOCAsaltand aortic coarctation-induced hypertention in mice:do kinin β2 receptors play a role? Hypertention, 1999, 33(1 pt 2):329-334

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部